EUVIMEDEUVIMED entdecken
Crossref

Oxcarbazepine – place in the treatment of epilepsy

Marcin Kopka

Medycyna Faktów · 2021

DOI: 10.24292/01.mf.0121.13 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medycyna Faktów, 2021. Verfasst von Marcin Kopka.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oxcarbazepine is recommended for the first line treatment of focal seizures in monotherapy and add-on therapy in both children and adults. It is well tolerated and less frequently interacts with other drugs, possible side effects less often lead to the cessation of the therapy. An important feature of the drug is a positive effect on the sexual sphere of patients and a presumed positive effect on reducing depressive symptoms.

Zitieren

APA

Kopka, M. (2021). Oxcarbazepine – place in the treatment of epilepsy. Medycyna Faktów. https://doi.org/10.24292/01.mf.0121.13

Vancouver

Kopka M. Oxcarbazepine – place in the treatment of epilepsy. Medycyna Faktów. 2021. doi:10.24292/01.mf.0121.13

BibTeX
@article{Kopka2021,
  author = {Kopka, Marcin},
  title = {Oxcarbazepine – place in the treatment of epilepsy},
  journal = {Medycyna Faktów},
  year = {2021},
  doi = {10.24292/01.mf.0121.13}
}
Kostenlos starten →